18 min

44: Mastering the Art and Science of Glycan Engineering in Drug Development w/ Henning von Horsten - Part 2 Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists

    • Life Sciences

Does uncovering the secrets of glycan engineering feel like navigating a maze of molecular complexity?
In this captivating continuation of our exploration into the world of glycan engineering, we delve deeper into groundbreaking innovations and the crucial role of analytics in ensuring consistent quality.
Henning von Horsten, Professor of Industrial Bioengineering at HTW Berlin (University of Applied Sciences in Berlin), shares the fascinating story behind a groundbreaking technology designed to modulate antibody-dependent cell-mediated cytotoxicity (ADCC).
You’ll get:
Learn how advancements in high-throughput techniques are streamlining analytics for quicker insights and data-driven optimizations.Explore the future of glycan engineering, which may lead to more effective therapeutics.Understand why glycans matter across various fields of biotechnology, including monoclonal antibodies and vaccines, and discover their pivotal role in shaping the future of healthcare.Connect with Henning von Horsten:
LinkedIn: https://www.linkedin.com/in/henning-von-horsten-b259102/Website: https://lsm.htw-berlin.de/team/prof-dr-rer-nat-hans-henning-von-horsten/Next Step:
Elevate your bioprocess development strategy — Schedule your free assessment now: https://bruehlmann-consulting.com/assessment

Does uncovering the secrets of glycan engineering feel like navigating a maze of molecular complexity?
In this captivating continuation of our exploration into the world of glycan engineering, we delve deeper into groundbreaking innovations and the crucial role of analytics in ensuring consistent quality.
Henning von Horsten, Professor of Industrial Bioengineering at HTW Berlin (University of Applied Sciences in Berlin), shares the fascinating story behind a groundbreaking technology designed to modulate antibody-dependent cell-mediated cytotoxicity (ADCC).
You’ll get:
Learn how advancements in high-throughput techniques are streamlining analytics for quicker insights and data-driven optimizations.Explore the future of glycan engineering, which may lead to more effective therapeutics.Understand why glycans matter across various fields of biotechnology, including monoclonal antibodies and vaccines, and discover their pivotal role in shaping the future of healthcare.Connect with Henning von Horsten:
LinkedIn: https://www.linkedin.com/in/henning-von-horsten-b259102/Website: https://lsm.htw-berlin.de/team/prof-dr-rer-nat-hans-henning-von-horsten/Next Step:
Elevate your bioprocess development strategy — Schedule your free assessment now: https://bruehlmann-consulting.com/assessment

18 min